Structure Based Design And Development Of Novel Xanthine Oxidase Inhibitors
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
A search for new xanthine inhibitor in underway worldwide which are devoid of liver and cardiac complications. The present work describes the structure-based drug design approach for the development of new xanthine oxidase inhibitors. Two protocols were adopted for the identification of potential compounds: I. Development of docking model to design of new xanthine oxidase inhibitors and II. Development of virtual screening pipeline to identify new xanthine oxidase inhibitor from publicly available natural compound database In the first protocol, the docking model was developed and validated using standard protocol. The docking model was used in docking simulation study of FDA approved xanthine oxidase inhibitors (allopurinol, febuxostat, and topiroxostat) which identified important amino acid residues involved in drug-receptor interactions. Docking study was extended on the recently published and patented molecules
newlineThe insight gained form this study was used to design some xanthine oxidase inhibitors. Their xanthine oxidase binding capacity in terms of Gold score was calculated. Here, we have achieved nearly 10% increase in their binding capacity compared to their original scaffold. To get synthetic exposure, a few pyrazoline derivatives were synthesized and evaluated for their xanthine oxidase inhibitory activity. Their activity was found comparable to allopurinol.
newlineIn the second protocol , we have developed an in silico virtual screening protocol to identify new hits for xanthine oxidase inhibitory activity. A database of 5339 compounds from natural source was retrieved from Zinc database. The naturally occurring compounds were selected as they are considered safe in comparison to their synthetic counterpart. Several physicochemical property filters related to druglikeliness were applied to screen-out the compound database). This resulted in 590 compounds with drug-like properties such as logP lt 5; MW lt 500 etc. The dataset of resulting 590 compounds was optimized for their geometry and used in docking-based vir